Literature DB >> 16628085

XIAP is related to the chemoresistance and inhibited its expression by RNA interference sensitize pancreatic carcinoma cells to chemotherapeutics.

Yixiong Li1, Zhiyuan Jian, Kun Xia, Xiaogang Li, Xinsheng Lv, Haiping Pei, Zhikang Chen, Jindong Li.   

Abstract

OBJECTIVES: To explore the exact role does the x-linked inhibitor of apoptosis (XIAP) play in chemoresistance of pancreatic carcinoma cell and the cell sensitivity to chemotherapeutic drugs changed after XIAP is inhibited by RNA interference (RNAi).
METHODS: Pancreatic carcinoma cell line SW1990 was exposed to 5-fluorouracil (5-fu) with the concentrations of 1.0 and 10 mug/mL to increase the expression of XIAP. Then 4 RNAi plasmid vectors against XIAP were designed and constructed, then transfected into SW1990. Repressive effect was evaluated by reverse transcriptase polymerase chain reaction and Western blot; 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide and flow cytometry were performed to determine cell sensitivity to 5-fu and gemcitabine; furthermore, apoptosis is confirmed by Hoechst 33258 stain.
RESULTS: XIAP of SW1990 can be up-regulated with the chemoresistance increasing 1.5- and 4-fold after 10 and 30 days induced by 5-fu. Two of the 4 vectors can inhibit the expression of XIAP protein more than 60%. The cells apoptosis index induced by 5-fu and gemcitabine increased greatly after XIAP is inhibited by the RNAi plasmid vectors.
CONCLUSIONS: XIAP is one of the most important factors in the pancreatic carcinoma chemoresistance, and inhibition of XIAP in pancreatic carcinoma can enhance the cancer sensitivity to chemotherapeutic drugs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628085     DOI: 10.1097/01.mpa.0000218314.67111.fb

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  20 in total

1.  AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.

Authors:  Melissa K Brunckhorst; Dimitry Lerner; Shaomeng Wang; Qin Yu
Journal:  Cancer Biol Ther       Date:  2012-06-06       Impact factor: 4.742

2.  Targeting X-linked inhibitor of apoptosis protein inhibits pancreatic cancer cell growth through p-Akt depletion.

Authors:  Chun Jiang; Xiao-Ping Yi; Hong Shen; Yi-Xiong Li
Journal:  World J Gastroenterol       Date:  2012-06-21       Impact factor: 5.742

3.  Smac mimetic increases chemotherapy response and improves survival in mice with pancreatic cancer.

Authors:  Sean P Dineen; Christina L Roland; Rachel Greer; Juliet G Carbon; Jason E Toombs; Puja Gupta; Nabeel Bardeesy; Haizhou Sun; Noelle Williams; John D Minna; Rolf A Brekken
Journal:  Cancer Res       Date:  2010-03-23       Impact factor: 12.701

4.  Down-regulation of BAX gene during carcinogenesis and acquisition of resistance to 5-FU in colorectal cancer.

Authors:  Mehdi Manoochehri; Ashraf Karbasi; Mojgan Bandehpour; Bahram Kazemi
Journal:  Pathol Oncol Res       Date:  2013-10-14       Impact factor: 3.201

5.  Co-expression of XIAP and CIAP1 Play Synergistic Effect on Patient's Prognosis in Head and Neck Cancer.

Authors:  Xi-Hu Yang; Liu Liu; Yong-Jie Hu; Ping Zhang; Qin-Gang Hu
Journal:  Pathol Oncol Res       Date:  2018-11-12       Impact factor: 3.201

6.  Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer.

Authors:  Irene Esposito; Jörg Kleeff; Ivane Abiatari; Xined Shi; Nathalia Giese; Frank Bergmann; Wilfried Roth; Helmut Friess; Peter Schirmacher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

7.  XIAP antisense oligonucleotide (AEG35156) achieves target knockdown and induces apoptosis preferentially in CD34+38- cells in a phase 1/2 study of patients with relapsed/refractory AML.

Authors:  Bing Z Carter; Duncan H Mak; Stephen J Morris; Gautam Borthakur; Elihu Estey; Anna L Byrd; Marina Konopleva; Hagop Kantarjian; Michael Andreeff
Journal:  Apoptosis       Date:  2011-01       Impact factor: 4.677

8.  Targeting the apoptotic machinery in pancreatic cancers using small-molecule antagonists of the X-linked inhibitor of apoptosis protein.

Authors:  Collins A Karikari; Indrajit Roy; Eric Tryggestad; Georg Feldmann; Clemencia Pinilla; Kate Welsh; John C Reed; Elwood P Armour; John Wong; Joseph Herman; Dinesh Rakheja; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2007-03-05       Impact factor: 6.261

9.  Quantitative high-throughput efficacy profiling of approved oncology drugs in inflammatory breast cancer models of acquired drug resistance and re-sensitization.

Authors:  Kevin P Williams; Jennifer L Allensworth; Shalonda M Ingram; Ginger R Smith; Amy J Aldrich; Jonathan Z Sexton; Gayathri R Devi
Journal:  Cancer Lett       Date:  2013-05-17       Impact factor: 8.679

10.  Pancreatic cancer-specific cell death induced in vivo by cytoplasmic-delivered polyinosine-polycytidylic acid.

Authors:  Praveen Bhoopathi; Bridget A Quinn; Qin Gui; Xue-Ning Shen; Steven R Grossman; Swadesh K Das; Devanand Sarkar; Paul B Fisher; Luni Emdad
Journal:  Cancer Res       Date:  2014-09-09       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.